A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : TNF-alpha

Search Conditions:
Search Keyword : TNF-alpha
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: TNF-alpha
Appearance Frequency: 48547 time(s)
Long forms: 25

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
tumor necrosis factor-alpha
(48497 times)
Allergy and Immunology
(6758 times)
IL-6 (8299 times)
LPS (5675 times)
IL-1beta (5533 times)
0 Tumor Necrosis Factor Alpha Signaling in Trigeminal Ganglion Contributes to Mechanical Hypersensitivity in Masseter Muscle During Temporomandibular Joint Inflammation.
alpha-tumor necrosis factor
(10 times)
Obstetrics
(3 times)
IL-1beta (2 times)
ADG (1 time)
ALT (1 time)
2000 Effects of nickel sulfate on pulmonary natural immunity in Wistar rats.
transforming growth factor-alpha
(7 times)
Biochemistry
(3 times)
COX-2 (3 times)
IL-10 (2 times)
IL-6 (2 times)
2008 Accelerated Ulcer Healing and Resistance to Ulcer Recurrence with Gastroprotectants in Rat Model of Acetic Acid-induced Gastric Ulcer.
transforming necrosis factor alpha
(5 times)
Allergy and Immunology
(2 times)
CRP (1 time)
ELISA (1 time)
ICAM-I (1 time)
1999 Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes.
Tumor necrosis factor-alpha/cachectin
(5 times)
Allergy and Immunology
(2 times)
anti-hTNF-alpha (1 time)
Bo rIFN-gamma (1 time)
BP (1 time)
1987 Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
inflammation-tumor necrosis factor-alpha
(2 times)
Critical Care
(1 time)
ALI (1 time)
BALF (1 time)
BMI (1 time)
2015 Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors.
treated with antitumour necrosis factor-alpha
(2 times)
Medicine
(1 time)
--- 2014 Anti-TNF-alpha and risk of infections: the experience in one center.
tumor inflammatory factor-alpha
(2 times)
Veterinary Medicine
(2 times)
AST (2 times)
LPS (2 times)
APS (1 time)
2019 Effects of Clostridium butyricum and Enterococcus faecalis on growth performance, intestinal structure, and inflammation in lipopolysaccharide-challenged weaned piglets.
(NF-kappaB)-tumor necrosis factor alpha
(1 time)
Microbiological Phenomena
(1 time)
Mtb (1 time)
NF-kappaB (1 time)
PE domain (1 time)
2020 PE_PGRS31-S100A9 Interaction Promotes Mycobacterial Survival in Macrophages Through the Regulation of NF-kappaB-TNF-alpha Signaling and Arachidonic Acid Metabolism.
10  Anti-Tnf-alpha/FNAB/PC-Au for protein biomarker
(1 time)
Biotechnology
(1 time)
FNAB (1 time)
PBS-T20 (1 time)
PC (1 time)
2017 On-chip electrochemical immunoassay platform for specific protein biomarker estimation in undiluted serum using off-surface membrane matrix.
11  non-smokers.Tumor necrosis factor-alpha
(1 time)
Pulmonary Medicine
(1 time)
BAL (1 time)
COPD (1 time)
IL-6 (1 time)
2014 Compartment differences of inflammatory activity in chronic obstructive pulmonary disease.
12  pathways—tumor necrosis factor-alpha
(1 time)
Dermatology
(1 time)
IL-23 (1 time)
Th17 (1 time)
2020 Real-World Clinical Experience With the IL-17 Receptor A Antagonist Brodalumab
13  production--tumour necrosis factor-alpha
(1 time)
Virology
(1 time)
EIAV (1 time)
HIV (1 time)
IFN-alpha (1 time)
1997 Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia.
14  T cell, could activate neither macrophage production of inflammatory cytokines
(1 time)
Allergy and Immunology
(1 time)
--- 1996 Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice.
15  thymus and spleen weights as well as serum necrosis factor-alpha
(1 time)
Biochemistry
(1 time)
IL-2 (1 time)
MW (1 time)
Se (1 time)
2016 Anti-tumor and immunomodulatory activity of selenium (Se)-polysaccharide from Se-enriched Grifola frondosa.
16  transcription factor NF-kappaB, an enhanced production of proinflammatory cytokines
(1 time)
HGF (1 time)
NPs (1 time)
2019 Molecular Responses in THP-1 Macrophage-Like Cells Exposed to Diverse Nanoparticles.
17  treatment strategies for Crohn's disease including antitumor necrosis factor-alpha
(1 time)
Pediatrics
(1 time)
GH (1 time)
IGF (1 time)
IL-6 (1 time)
2011 The role of growth hormone and insulin-like growth factor-1 in Crohn's disease: implications for therapeutic use of human growth hormone in pediatric patients.
18  tube dilution method, lymphocyte proliferation, and pro-inflammatory cytokines
(1 time)
Pharmacology
(1 time)
--- 2015 Immunosuppressive potential of Botryosphaeria dothidea, an endophyte isolated from Kigelia africana.
19  tumor necreactive oxygen speciesis factor-alpha
(1 time)
Pharmacology
(1 time)
AD (1 time)
COX-2 (1 time)
GCLM (1 time)
2017 L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: Involvement of NF-kappaB inhibition and Nrf2 pathway activation.
20  tumor necrosis alpha-factor
(1 time)
Medicine
(1 time)
--- 1996 [Correlation between histocompatibility antigens, tumor necrosis factor-alpha, and HIV infection].
21  tumor necrosis factor-alpha expression
(1 time)
Biochemistry
(1 time)
IL-1 (1 time)
1997 Interleukin-1 stimulates tumor necrosis factor-alpha (TNF-alpha) release from cytotrophoblastic BeWo cells independently of induction of the TNF-alpha mRNA.
22  Tumor Necrosis Factor-alpha serum concentration
(1 time)
Biology
(1 time)
--- 1996 Evolution of tumor necrosis factor-alpha serum concentrations in HIV infected individuals treated with zidovudine.
23  tumour necrosis factor alpha superfamily
(1 time)
Biochemistry
(1 time)
TL1A (1 time)
2019 Tumour necrosis factor like cytokine 1A levels and lesion complexity in non-smoking patients with coronary artery disease.
24  tumour necrosis factor-alpha production
(1 time)
Cell Biology
(1 time)
IA (1 time)
2018 Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase.
25  type and number of infiltrating cells, changes in protein, cytokine
(1 time)
Dermatology
(1 time)
DNFB (1 time)
EGFRIs (1 time)
SCF (1 time)
2011 Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling.